| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals, Inc. (TARS) has 12 insiders with recent SEC Form 4 filings, including 6 buys and 2 sells. TARS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.5K | $52.55M | - | |
| Dir | 128.8K | $7.89M | - | |
| COO | 79.2K | $4.85M | - | |
| Other | 47.6K | $2.91M | - | |
| Other | 36.7K | $2.25M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2021 | Rtw Investments, LP80 | 10% Owner | Sell | 450,000 | $29.98 | $13,491,000.00 | -18.3% | -16.7% | -63.0% | |
| Apr 14, 2021 | Vivo Capital Ix, LLC57 | 10% Owner | Sell | 400 | $30.37 | $12,148.00 | - | -7.6% | -38.8% | |
| Oct 20, 2020 | Vivo Capital Ix, LLC57 | 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +8.3% | - | - | |
| Oct 20, 2020 | Tester Jason E. | Director, 10% Owner | Buy | 171,875 | $16.00 | $2,750,000.00 | +9.7% | - | - | |
| Oct 20, 2020 | Frazier Life Sciences Ix, L.P. | 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +19.5% | - | - | |
| Oct 20, 2020 | Horowitz Limited Partnership VIII | 10% Owner | Buy | 184,375 | $16.00 | $2,950,000.00 | +10.2% | - | - |